# BAL Fluid Biomarkers in Sarcoma

> **NCT06815666** · PHASE2 · RECRUITING · sponsor: **University Health Network, Toronto** · enrollment: 70 (estimated)

## Conditions studied

- Soft Tissue Sarcoma (STS)
- Bronchoalveolar Lavage (BAL)
- Bronchoalveolar Lavage Fluid

## Interventions

- **PROCEDURE:** Bronchoscopy & Metastasectomy

## Key facts

- **NCT ID:** NCT06815666
- **Lead sponsor:** University Health Network, Toronto
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-01-29
- **Primary completion:** 2032-04-01
- **Final completion:** 2032-04-01
- **Target enrollment:** 70 (ESTIMATED)
- **Last updated:** 2026-03-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06815666

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06815666, "BAL Fluid Biomarkers in Sarcoma". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT06815666. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*